Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamed A Bakr

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 2, 2005
Induction therapyMohamed A Bakr
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 15, 2010
Proteinuria among primarily sirolimus treated live-donor renal transplant recipients' long-term experienceAhmed F Hamdy, Mohamed A Bakr, Mohamed A Ghoneim
Journal of the American Society of Nephrology : JASN|March 14, 2008
Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipientsAhmed F Hamdy, Mohamed A Bakr, Mohamed A Ghoneim
Clinical and Experimental Nephrology|January 21, 2009
Hemolytic anemia after ABO nonidentical living donor kidney transplantationMohamed A Bakr, Tarek M Abbas, Amany Mustafa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2009
Nail changes in kidney transplant recipientsAbeer M Abdelaziz, Khaled M Mahmoud, Essam M Elsawy, et al.
American Journal of Nephrology|April 25, 2003
Death with functioning graft in living donor kidney transplantation: analysis of risk factorsAmgad E El-Agroudy, Mohamed A Bakr, Ahmed B Shehab El-Dein, et al.
Clinical Transplantation|December 15, 2018
Outcome of sirolimus-based immunosuppression, fifteen years post-live-donor kidney transplantation: Single-center experienceAhmed F Hamdy, Muhammed A Elhadedy, Ahmed F Donia, et al.
International Urology and Nephrology|November 6, 2007
Long-term evaluation of single bolus high dose ATG induction therapy for prophylaxis of rejection in live donor kidney transplantationHussein A Sheashaa, Ahmed F Hamdy, Mohamed A Bakr, et al.
Clinical and Experimental Nephrology|June 28, 2005
Glutathione peroxidase activity in patients with renal disordersMohamed A El-Far, Mohamed A Bakr, Sami E Farahat, et al.
Journal of Nephrology|July 2, 2003
Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trialHussein A Sheashaa, Mohamed A Bakr, Amany M Ismail, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 2, 2005
Induction therapyMohamed A Bakr
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 15, 2010
Proteinuria among primarily sirolimus treated live-donor renal transplant recipients' long-term experienceAhmed F Hamdy, Mohamed A Bakr, Mohamed A Ghoneim
Journal of the American Society of Nephrology : JASN|March 14, 2008
Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipientsAhmed F Hamdy, Mohamed A Bakr, Mohamed A Ghoneim
Clinical and Experimental Nephrology|January 21, 2009
Hemolytic anemia after ABO nonidentical living donor kidney transplantationMohamed A Bakr, Tarek M Abbas, Amany Mustafa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2009
Nail changes in kidney transplant recipientsAbeer M Abdelaziz, Khaled M Mahmoud, Essam M Elsawy, et al.
American Journal of Nephrology|April 25, 2003
Death with functioning graft in living donor kidney transplantation: analysis of risk factorsAmgad E El-Agroudy, Mohamed A Bakr, Ahmed B Shehab El-Dein, et al.
Clinical Transplantation|December 15, 2018
Outcome of sirolimus-based immunosuppression, fifteen years post-live-donor kidney transplantation: Single-center experienceAhmed F Hamdy, Muhammed A Elhadedy, Ahmed F Donia, et al.
International Urology and Nephrology|November 6, 2007
Long-term evaluation of single bolus high dose ATG induction therapy for prophylaxis of rejection in live donor kidney transplantationHussein A Sheashaa, Ahmed F Hamdy, Mohamed A Bakr, et al.
Clinical and Experimental Nephrology|June 28, 2005
Glutathione peroxidase activity in patients with renal disordersMohamed A El-Far, Mohamed A Bakr, Sami E Farahat, et al.
Journal of Nephrology|July 2, 2003
Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trialHussein A Sheashaa, Mohamed A Bakr, Amany M Ismail, et al.
Pageof 4